 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

---
- This is a signal that CRY's price could be shifting from a downtrend to an uptrend.
  Traders may consider buying the stock or exploring call options...


CryoLife (CRY, $17.88) RSI Indicator left the oversold zone on January 21, 2022

---
- Zacks Investment Research lowered shares of CryoLife (NYSE:CRY) from a hold rating
  to a sell rating in a research note published on Monday, Zacks.com reports. According
  to Zacks, CryoLife, Inc. is a leader in medical device manufacturing and distribution
  and in the processing and distribution...


Zacks Investment Research Downgrades CryoLife (NYSE:CRY) to Sell

CryoLife (CRY, $17.63) RSI Indicator left the oversold zone on January 20, 2022

---
- Zacks Investment Research cut shares of CryoLife (NYSE:CRY) from a hold rating to
  a sell rating in a research report sent to investors on Monday morning, Zacks.com
  reports. According to Zacks, CryoLife, Inc. is a leader in medical device manufacturing
  and distribution and in the processing and ...


CryoLife (NYSE:CRY) Downgraded by Zacks Investment Research

---
- Skandinaviska Enskilda Banken AB publ trimmed its holdings in shares of CryoLife,
  Inc. (NYSE:CRY) by 17.7% in the 3rd quarter, according to the company in its most
  recent 13F filing with the Securities and Exchange Commission. The firm owned 45,159
  shares of the medical equipment providers ...


CryoLife, Inc. (NYSE:CRY) Shares Sold by Skandinaviska Enskilda Banken AB publ

---
- CryoLife Announces Corporate Rebranding and Changes Name to Artivion CryoLife Announces
  Corporate Rebranding and Changes Name to Artivion Artivion to Host Investor & Analyst
  Day on March 23, 2022 PR Newswire ATLANTA, Jan. 18, 2022 ATLANTA, Jan. 18, 2022
  /PRNewswire/ -- CryoLife, Inc. (NYSE...


CryoLife Announces Corporate Rebranding and Changes Name to Artivion

---
- The following slide deck was published by CryoLife, Inc.


CryoLife (CRY) Investor Presentation (Slideshow)

---
- Zacks Investment Research downgraded shares of CryoLife (NYSE:CRY) from a strong-buy
  rating to a hold rating in a research note issued to investors on Monday, Zacks.com
  reports. According to Zacks, CryoLife, Inc. is a leader in medical device manufacturing
  and distribution and in the ...


---
- This is a Bearish indicator signaling CRY's price could decline from here. Traders
  may explore shorting the stock or put options...


CryoLife (CRY, $19.58) Moving Average Convergence Divergence (MACD) Histogram turned negative on January 11, 2022

---
- CryoLife (NYSE:CRY) had its price target lowered by Morgan Stanley from $29.00 to
  $25.00 in a research note issued to investors on Friday, Analyst Ratings Network
  reports. Morgan Stanley currently has an equal weight rating on the medical equipment
  providers stock. Separately, Zacks ...


CryoLife (NYSE:CRY) Price Target Cut to $25.00 by Analysts at Morgan Stanley

Artivion, Inc. engages in the research and development of solutions which address cardiac and vascular surgeons' clinical challenges in treating patients with aortic diseases. Its products include aortic stents and stent grafts, prosthetic heart valves, cryopreserved cardiac and vascular allografts, and surgical sealants. It operates through the Medical Devices and Preservation Services segments. The Medical Devices segment includes aortic stents and stent grafts, surgical sealants, and On-X products. The Preservation Services segment offers cardiac and vascular tissue preservation services. The company was founded on January 19, 1984 and is headquartered in Kennesaw, GA.

Watchers	483
52-Wk Low	$9.64
52-Wk High	$18.00

Market Cap	$618.06M
Volume (M)	35,504.00
52-Wk High	$18.00
52-Wk Low	$9.64

CRY CryoLife Inc.

About

Feed

News

Fundamentals